Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2025-12-24 @ 9:58 PM
NCT ID: NCT01547832
Eligibility Criteria: * INCLUSION CRITERIA: Parkinson s Subjects: Screening: * Age 18 years to 80 years old with a history of early onset Parkinson disease (Presentation within the first five decades of life). * Diagnosis of Parkinson disease or Parkinsonism * Willingness and legal ability to give and sign informed study consent Enrollment: * Mutations in PARK2 * Willingness to travel to NIH for scheduled protocol studies Control Subjects: * Age 18 years to 80 years old with no history or family history of Parkinson disease. * Willingness and legal ability to give and sign informed study consent * Willingness to travel to NIH for scheduled protocol studies * Willingness to have blood or tissue samples studied, and potentially stored for future research EXCLUSION CRITERIA: \<TAB\> Parkinson Subjects: Screening: * Subjects who are unable or unwilling to sign an informed consent subjects with genetic defects associated with other diseases including other neurologic syndromes. * Subjects without medically treated diabetes who are unable/unwilling to undergo a glucose tolerance test Enrollment: \- Pregnancy Control Subjects * Subjects who are unable or unwilling to sign an informed consent * Subjects with genetic defects associated with other diseases including other neurologic syndromes. * Pregnancy * Medically treated diabetes * Unable/unwilling to undergo a glucose tolerance test
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT01547832
Study Brief:
Protocol Section: NCT01547832